EverSource Wealth Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9K Sell
315
-884
-74% -$75.1K ﹤0.01% 2272
2026
Q1
$103K Buy
1,199
+632
+111% +$56.7K ﹤0.01% 1406
2025
Q4
$49.5K Buy
567
+107
+23% +$8.12K ﹤0.01% 1755
2025
Q3
$26.3K Sell
460
-2
-0.4% -$115 ﹤0.01% 2149
2025
Q2
$27.3K Buy
462
+197
+74% +$12.7K ﹤0.01% 2052
2025
Q1
$19.4K Buy
265
+5
+2% +$413 ﹤0.01% 1700
2024
Q4
$21.5K Buy
260
+82
+46% +$6.47K ﹤0.01% 1584
2024
Q3
$12.7K Buy
178
+15
+9% +$1.06K ﹤0.01% 1735
2024
Q2
$11.7K Sell
163
-14
-8% -$836 ﹤0.01% 1764
2024
Q1
$8.81K Buy
177
+43
+32% +$2.31K ﹤0.01% 1757
2023
Q4
$7.14K Buy
134
+21
+19% +$1.02K ﹤0.01% 1712
2023
Q3
$5.61K Buy
+113
New +$6.32K ﹤0.01% 1664
2023
Q2
Sell
-16
Closed -$906 2538
2023
Q1
$906 Sell
16
-4,114
-100% -$264K ﹤0.01% 2135
2022
Q4
$307K Sell
4,130
-633
-13% -$43.1K 0.05% 275
2022
Q3
$284K Sell
4,763
-441
-8% -$26.6K 0.07% 245
2022
Q2
$292K Buy
+5,204
New +$342K 0.08% 214

Other funds holding GMED

EverSource Wealth Advisors's GMED Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Globus Medical (GMED) stake by 74% in Q2 2026, selling an estimated $75.1K and leaving 315 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2272.

EverSource Wealth Advisors first reported a position in GMED in Q2 2022 and has held it in 16 quarters since. The position peaked at $307K in Q4 2022. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • EverSource Wealth Advisors held 315 shares of Globus Medical worth $24.9K as of Q2 2026.
  • EverSource Wealth Advisors sold 884 Globus Medical shares in Q2 2026, an estimated $75.1K.
  • Globus Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2272 holding.
  • EverSource Wealth Advisors first reported a position in Globus Medical in Q2 2022 and has held it in 16 quarters since.
  • EverSource Wealth Advisors's Globus Medical position peaked at $307K in Q4 2022.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.